Generics & Biosimilars | Association for Accessible Medicines
Welcome Message - Blog from AAM President and CEO Dan Leonard: Generics: The Bridge to A Vaccine.
  • #SecureOurMeds
    Plan to Secure Our Medicines
    The U.S. generics and biosimilars industry, makers of 90% of our nation's prescription medicines, has a plan to #SecureOurMeds. We already produce billions of doses domestically and our plan ensures continued patient access through COVID and beyond.
    Watch Video
  • Christine Simmon Invites You to GRx+Biosims 2020
    You Are Invited to GRx+Biosims 2020
    Christine Simmon, AAM SVP Policy and Executive Director of the Biosimilars Council, invites a global audience to join GRx+Biosims 2020 on November 9-11, 2020. Take a deep dive into the policy & regulatory challenges facing the U.S. biosimilars market.
    Watch Video
  • Connect With Industry Experts
    Looking to be inspired? Join us for the GRx+Biosims 2020 virtual conference on November 9-11, 2020. Attending the GRx+Biosims conference has never been easier or less expensive.
  • AAM Blueprint U.S. Supply Chain
    Securing the U.S. Rx Supply Chain
    The generic drug industry in the U.S. can expand domestically to increase national security, lessen dependence on any single country and create more jobs. Learn about our plan.
  • ""
    Industry Response to COVID-19
    The coronavirus (COVID-19) pandemic is disrupting everyday life around the world and imposing unprecedented stress on our health care system. Here are some responses and resources from the U.S. generics and biosimilars industry.

Association for Accessible Medicines

202.249.7100

Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.